Key Takeaways Expansion in high-growth infusion therapies and payer partnerships is broadening patient reach, supporting sustained revenue growth and enhanced pricing power. Investments in technology, clinical efficiency, and strategic capital deployment are driving margin improvements, new revenue streams, and long-term earnings expansion.